PREVALENCE OF THYROID DYSFUNCTION AMONG TYPE 2 DIABETES MELLITUS IN URBAN AREAS OF BELAGAVI, KARNATAKA, INDIA
Main Article Content
Keywords
Type 2 Diabetes mellitus, Thyroid dysfunction, Prevalence, Hypothyroidism
Abstract
Introduction: Diabetes is a major disease burden in India and we are home to the second largest number of diabetes cases in the world with currently over 74.2 million cases of diabetes. Type 2 diabetes mellitus and thyroid disorders are highly prevalent disorders in the community. Both have been shown to mutually influence each other. Recognition of this interdependent relationship between thyroid disease and diabetes is of significance in guiding clinicians towards optimal management of both these conditions. Objective: To determine the prevalence of thyroid dysfunction among type 2 diabetes mellitus patients and the risk factors associated with it. Methodology: Data was collected from type 2 diabetes mellitus patients residing in areas under the Urban Health Centre Ashok Nagar and Rukmini Nagar, Belagavi. Study participants were selected based on the selection criteria. Information about socio-demographic profile, risk behaviors, general physical examination, systemic and thyroid examination were collected. Venous blood samples were collected to estimate thyroid profile (T3, T4, TSH), FBS and PPBS. Results: The prevalence of thyroid disorders was 21.58%. Sub-clinical hypothyroidism was more common than other conditions which constituted 13.68% of the thyroid dysfunction in the type 2 diabetes mellitus patients. Statistically significant association was observed with factors such as gender, physical activity during leisure time, waist hip ratio and glycemic status with p value less than 0.05. Multivariate analysis demonstrated the presence of thyroid disorder was related with glycemic status of the participants with odds ratio 1.85 (CI, 0.996 – 3.443). Conclusion: This study shows that a significant proportion of type 2 diabetes patients suffer from thyroid dysfunction and screening for the same should be routinely considered, as it is found to be an additional co-morbidity.
References
2. World Health Organization (WHO). Obesity: preventing and managing the global epidemic. Report of a WHO consultation. (1-253).World Health Organ Tech Rep Ser. 2000;894:i–xii.
3. Pradeepa R, Anjana RM, Joshi SR, et al. Prevalence of generalized & abdominal obesity in urban & rural India--the ICMR-INDIAB Study (Phase-I) [ICMR- NDIAB-3]. Indian J Med Res. 2015;142(2):139–150. doi:10.4103/0971-5916.164234
4. American Association of Diabetes Educators, Chicago, IL, August 2018.
5. Damian J. Damian, Kelvin Kimaro, Godwin Mselle, Rose Kaaya and Isaac Lyaruu. Prevalence of overweight and obesity among type 2 diabetic patients attending diabetes clinics in northern Tanzania. BMC research notes (2017) 10:515
6. Ahmad Shirafkan and Abdoljalal Marjani. Prevalence of Obesity Among Type 2 Diabetes Mellitus In Gorgan (South East of Caspian Sea), Iran. World Applied Sciences Journal 14 (9): 1389-1396, 2011
7. Rao C, Kamath V, Shetty A, Kamath A. A study on the prevalence of type 2 diabetes in coastal Karnataka. Int J Diabetes Dev Ctries 2010;30(2):80
8. Singh T, Sharma S, Nagesh S. Socio-economic status scales updated for 2017. Int J Res Med Sci 2017;5(7):3264
9. Joshi SR. Laboratory evaluation of thyroid function. J Assoc Physicians India 2011;59 Suppl(January):14–20.
10. Hsio- M, Wiedmeyer M. Laboratory Procedure Manual Plasma Glucose Enzyme Hexokinase (HK). :1–14.
11. WHO. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Who2 2006;50.
12. Jali MV, Kambar S, Jali SM, Pawar N, Nalawade P. Prevalence of thyroid dysfunction among type 2 diabetes mellitus patients. Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S105-S108. doi: 10.1016/j.dsx.2016.12.017. Epub 2016 Dec 19. PMID: 28057505.
13. Sreelatha M, Kumar VS, Shekar GC, Shekar VC. Study of Thyroid Profile in Patients with Type 2 Diabetes Mellitus. 2017;5(2):211–20
14. Setare Nassiri, Mohammad Vakili, Hamide Gholami and Setare Akhavan 2018. “Prevalence of thyroid dysfunction in patients of type 2 diabetes mellitus: hospital based prospective study”, International Journal of Current Research 10, (03), 67031-67034.
15. Dr AnuradhaDeurietal, 2016. (22. 5%)1: Prospective study of thyroid dysfunction in patients with Type 2 diabetes mellitus in a tertiary care hospital, Assam, India. IOSR Journal of Dental and Medical Sciences, volume 15, issue 7 ver. Ii, pp21-25).
16. Ozair, Maaz & Noor, Saba & Raghav, Alok & Siddiqi, Sheelu & Chugtai, Anjum & Ahmad, Jamal. (2017). Prevalence of Thyroid Disorders in North Indian Type 2 Diabetic Subjects: A cross sectional study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 12. 10.1016/j.dsx.2017.12.016.
17. Kaeley, Nidhi & Bhatia, Rohan & Dhar, Minakshi & Verma, Sanjiv & Ahmad, Sohaib. (2015). Kaeley et al.: Association of thyroid disorders and type 2 Diabetes Mellitus ASSOCIATION OF THYROID DISORDERS AND TYPE 2 DIABETES MELLITUS-BEYOND COINCIDENCE-A HOSPITAL BASED STUDY FROM SUB-HIMALAYAN REGION.
18. Navneet Agrawal, Manoj Gulati. Study of prevalence of thyroid dysfunction in patients with type 2 diabetes mellitus. International Journal of Contemporary Medical Research 2016;3(8):2212-2214
19. Palma CC, Pavesi M, Nogueira VG, Clemente EL, Vasconcellos Mde F, Pereira LC Júnior, Pacheco FF, Braga TG, Bello Lde F, Soares JO, Dos Santos SC, Campos VP, Gomes MB. Prevalence of thyroid dysfunction in patients with diabetes mellitus. Diabetol Metab Syndr. 2013 Oct 9;5(1):58. doi: 10.1186/1758-5996-5-58. PMID: 24499529; PMCID: PMC3852595.
20. Papazafiropoulou, A., Sotiropoulos, A., Kokolaki, A. et al. 2010. Prevalence of thyroid dysfunction among greek type 2 diabetic patients attending an outpatient clinic. J Clinical Medicine Research, 2 (2): 75-8. 5.
21. Manjunath SC, Krishnamurthy V, Puttaswamy BK, Prabhu S, Vishwanathaiah PM. Prevalence of subclinical thyroid disorders in type 2 diabetes mellitus. Int J Med Public Health 2013;3:330-4.
22. Bharat, Hijam D, Gangte D, Lalnunpui, Premchand, et al. (2013) Thyroid Status in Diabetes Mellitus. J Glycomics Lipidomics 3: 106. doi:10.4172/2153 0637.1000106